Phase I study of amrubicin (AMR) for patients (pts) with previously treated small cell lung cancer (SCLC)

被引：0
|
作者：
Katakami, N.
Hata, A.
Yoshioka, H.
Higashi, Y.
Nishimura, T.
Sakaguchi, S.
Hayashi, M.
Tomii, K.
Naya, R.
Ishihara, K.
机构：
[1] Kobe City Gen Hosp, Kobe, Hyogo, Japan
[2] Kurashiki Cent Hosp, Kurashiki, Okayama, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
18209
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A phase II study of S-1 for previously treated small cell lung cancer (SCLC)
    Kudo, K.
    Ohyanagi, F.
    Horiike, A.
    Miyauchi, E.
    Motokawa, I.
    Horai, T.
    Mun, M.
    Sakao, Y.
    Okumura, S.
    Nakagawa, K.
    Nishio, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [22] Phase I dose escalation study of amrubicin plus paclitaxel in previously treated advanced non-small cell lung cancer
    Kyoichi Kaira
    Noriaki Sunaga
    Hisao Imai
    Yosuke Kamide
    Yasuhiko Koga
    Akihiro Ono
    Tomohito Kuwako
    Tomomi Masuda
    Takeshi Hisada
    Tamotsu Ishizuka
    Masanobu Yamada
    International Journal of Clinical Oncology, 2016, 21 : 240 - 247
  • [23] Phase I dose escalation study of amrubicin plus paclitaxel in previously treated advanced non-small cell lung cancer
    Kaira, Kyoichi
    Sunaga, Noriaki
    Imai, Hisao
    Kamide, Yosuke
    Koga, Yasuhiko
    Ono, Akihiro
    Kuwako, Tomohito
    Masuda, Tomomi
    Hisada, Takeshi
    Ishizuka, Tamotsu
    Yamada, Masanobu
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2016, 21 (02) : 240 - 247
  • [24] Phase I study of amrubicin and vinorelbine in non-small cell lung cancer previously treated with platinum-based chemotherapy
    Oizumi, Satoshi
    Yamazaki, Koichi
    Yokouchi, Hiroshi
    Konishi, Jun
    Hommura, Fumihiro
    Kojima, Tetsuya
    Isobe, Hiroshi
    Nishimura, Masaharu
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2009, 14 (02) : 125 - 129
  • [25] Phase II study of amrubicin (AMR) in patients (pts) with non-small cell lung cancer (NSCLC) previously treated with platinum-based chemotherapy, a further analysis on adverse effect: WJTOG0401
    Sawa, T.
    Kaneda, H.
    Okamoto, I.
    Hayshi, H.
    Kudoh, S.
    Takeda, K.
    Satouchi, M.
    Iwamoto, Y.
    Gotoh, I.
    Nakagawa, K.
    EJC SUPPLEMENTS, 2009, 7 (02): : 526 - 527
  • [26] Phase I study of amrubicin and vinorelbine in non-small cell lung cancer previously treated with platinum-based chemotherapy
    Satoshi Oizumi
    Koichi Yamazaki
    Hiroshi Yokouchi
    Jun Konishi
    Fumihiro Hommura
    Tetsuya Kojima
    Hiroshi Isobe
    Masaharu Nishimura
    International Journal of Clinical Oncology, 2009, 14 : 125 - 129
  • [27] A phase I study of amrubicin and carboplatin for previously untreated patients with extensive-disease small-cell lung cancer
    Takemoto, Shinnosuke
    Nagashima, Seiji
    Soda, Hiroshi
    Fukuda, Minoru
    Nakamura, Yoichi
    Iida, Tetsuya
    Nakatomi, Katsumi
    Kasai, Takashi
    Takatani, Hiroshi
    Fukuda, Masaaki
    Kinoshita, Akitoshi
    Soejima, Yoshifumi
    Oka, Mikio
    Kohno, Shigeru
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S468 - S469
  • [28] A phase I study of amrubicin and carboplatin for previously untreated patients with extensive-disease small-cell lung cancer
    Kasai, T.
    Fukuda, M.
    Nakamura, Y.
    Nakatomi, K.
    Iida, T.
    Fukuda, M.
    Kinoshita, A.
    Soda, H.
    Oka, M.
    Kohno, S.
    EJC SUPPLEMENTS, 2009, 7 (02): : 539 - 540
  • [29] PHASE II STUDY OF AMRUBICIN (AMR) COMBINED WITH CARBOPLATIN (CBDCA) FOR REFRACTORY RELAPSED SMALL CELL LUNG CANCER (SCLC): NORTH JAPAN LUNG CANCER GROUP 0802
    Oizumi, S.
    Inoue, A.
    Sakakibara, T.
    Asahina, H.
    Sugawara, S.
    Maemondo, M.
    Okudera, K.
    Suzuki, T.
    Usui, K.
    Harada, M.
    Morikawa, N.
    Hasegawa, Y.
    Ishimoto, O.
    Nukiwa, T.
    ANNALS OF ONCOLOGY, 2012, 23 : 105 - 105
  • [30] Phase II study of RAD001 (everolimus) in previously treated small cell lung cancer (SCLC)
    Kotsakis, Athanasios
    Tarhini, Ahmad
    Petro, Daniel
    Flaugh, Rick
    Vallabhaneni, Geetha
    Belani, Chandra
    Friedland, David
    Argiris, Athanassios
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S464 - S464
12345